Drug development is an arduous and expensive exercise. We seek to produce innovative compounds efficiently and effectively.

SEC Filings

Filing	Description	Date Filed	Size
4	mueller, peter	Mar 16, 2010	21.5 KB
4	brimblecombe, roger w	Mar 16, 2010	21.3 KB
S-3ASR	automatic shelf registration statement of securities of well-known seasoned issuers	Feb 19, 2010	808.9 KB
10-K	annual report	Feb 19, 2010	1.3 MB
4	mueller, peter	Feb 18, 2010	21.5 KB
4	winger, dennis l	Feb 18, 2010	19.2 KB
SC 13G/A	amended statement of beneficial ownership	Feb 16, 2010	56.0 KB
SC 13G/A	amended statement of beneficial ownership	Feb 16, 2010	22.3 KB
SC 13G/A	amended statement of beneficial ownership	Feb 12, 2010	12.8 KB
SC 13G/A	amended statement of beneficial ownership	Feb 12, 2010	18.1 KB
4	cordes, eugene	Feb 12, 2010	19.2 KB
SC 13G/A	amended statement of beneficial ownership	Feb 12, 2010	22.1 KB
SC 13G	statement of beneficial ownership	Feb 12, 2010	23.2 KB
SC 13G	statement of beneficial ownership	Feb 10, 2010	21.8 KB
4	sachdev, amit	Feb 8, 2010	21.0 KB
4	silva, paul m	Feb 8, 2010	21.0 KB
4	emmens, matthew	Feb 8, 2010	20.7 KB
4	boger, kenneth s	Feb 8, 2010	20.9 KB
4	mueller, peter	Feb 8, 2010	21.0 KB
4	smith, ian f	Feb 8, 2010	21.0 KB
Showing 1-20 of 1080 Page: 1 2 3 ... 54  Next 20